CelLBxHealth plc (AIM:CLBX)
London · Delayed Price · Currency is GBP · Price in GBX 0.8330
-0.0420 (-4.80%)
Sep 25, 2026, 4:07 PM GMT
CelLBxHealth Market Cap
CelLBxHealth has a market cap or net worth of 9.94 million as of September 25, 2026. Its market cap has increased by 2.23% in one year.
Market Cap
9.94M
Enterprise Value
8.38M
Revenue
1.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.83
ChartMarket Cap Chart
Since August 16, 2004, CelLBxHealth's market cap has decreased from 20.37M to 9.94M, a decrease of -51.18%. That is a compound annual growth rate of -3.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 9.94M | -20.45% |
| Dec 31, 2025 | 12.50M | -62.19% |
| Dec 31, 2024 | 33.06M | 8.02% |
| Dec 29, 2023 | 30.60M | -76.73% |
| Dec 30, 2022 | 131.54M | -52.97% |
| Dec 31, 2021 | 279.69M | 172.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 192.79B |
| GSK plc | 75.21B |
| Haleon | 30.38B |
| Smith & Nephew | 8.45B |
| Fusion Antibodies | 14.02M |
| Cambridge Cognition Holdings | 13.04M |
| Palatin Technologies | 12.90M |
| Aptamer Group | 11.23M |